t
On 30 July 2024, David Cicurel, CEO of Judges Scientific plc, gifted 40,000 ordinary shares of 5 pence each in the Company to his adult children for nil consideration. Following this transaction, his beneficial interest in the Company's ordinary shares is 604,337, and his combined beneficial and non-beneficial interest totals 671,337 ordinary shares.
| Date | 30 Jul 2024 |
| Time | 14:45:35 |
| Category | Director/PDMR dealings |
| ID | 4428Y |
Judges Scientific plc
Director/PDMR Shareholding
In accordance with notification obligations under article 19.3 of the Market Abuse Regulation, the Company announces that on 30 July 2024 David Cicurel, CEO, transferred by way of a gift 40,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares") in aggregate to his adult children.
Following this gift David Cicurel is beneficially interested in 604,337 Ordinary Shares and beneficially and non beneficially interested in 671,337 Ordinary Shares, his non beneficial interest comprising 67,000 Ordinary Shares he has gifted to Shoftim Charitable Trust.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
David Cicurel |
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
Chief Executive Officer |
||||
|
b)
|
Initial notification /Amendment
|
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
Name
|
Judges Scientific plc |
||||
|
b)
|
LEI
|
2138004EXWWPTW1JOL31 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in Judges Scientific plc
GB0032398678
|
||||
|
b)
|
Nature of the transaction
|
Gift of 40,000 Ordinary Shares to adult children |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (single transaction) |
||||
|
e)
|
Date of the transaction
|
30/07/2024 |
||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
||||
|
- For further information please contact:
|
|
|
|
|
Judges Scientific plc David Cicurel, CEO Brad Ormsby, CFO Tel: +44 (0) 20 3829 6970
|
Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Harry Davies-Ball Tel: +44 (0) 20 7408 4090
|
|
|
|
Liberum (Joint Broker) Edward Mansfield Nikhil Varghese Tel : +44 (0) 20 3100 2222
|
Investec Bank plc (Joint Broker) Virginia Bull Carlton Nelson Tel: +44 (0) 207 597 4000 |
|
|
|
Alma PR (Financial Public Relations) Sam Modlin Rebecca Sanders-Hewitt Joe Pederzolli Tel: +44 (0) 20 3405 0205 |
|
|
|
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 24 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com